Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis

Status unknownNot a drug-phase studyRelapsing MSNCT05615454

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • bio-electromagnetic energy regulation therapy (BEMER) machine model type: B.BOX CLASSIC, model NO: 420100, 12-15 Volt, (BEMER Int.AG, Liechtenstein product).

Placebo

  • placebo BEMER

What it measured

Main measures

  • International Index of Erectile Function - Erectile Function (IIEF-EF)

    Change from Baseline Erectile Function at 3 weeks

    Bladder, bowel and sexual function

Other measures (3)

  • The Arizona Sexual Experience (ASEX) Scale

    Within immediately of completion of the 3-week intervention period.

    Bladder, bowel and sexual functionQuality of life (reported by participants)
  • Modified Fatigue Impact Scale (MFIS)

    Within immediately of completion of the 3-week intervention period.

    Thinking and memoryFatigue
  • The Multiple Sclerosis, Intimacy, and Sexuality Questionnaire (MSISQ-19)

    Within immediately of completion of the 3-week intervention period.

    Bladder, bowel and sexual functionQuality of life (reported by participants)

Who could take part

Relapsing MS · 18 to 40

Show the full criteria

Inclusion criteria

* Diagnosis of MS according to the McDonald Revised criteria. * Score 6-25 on the International Index of Erectile Function 15 (IIEF-15) will be recruited. * Had sexual activity in the past month. * Have Relapsing-remitting MS (RRMS) type and one month of clinical relapse, at least before the experimental study date.

Exclusion criteria

* If they have cognitive impairment that causes problems in answering the questionnaire. * History of major chronic illness or other neurological disorders. * Received any treatment for ED in the past seven days * Previous therapy with a pulsed electromagnetic field, epilepsy, pacemaker, and acute bacterial infection with fever.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple sclerosis (MS) is an inflammatory disease that affects the brain and spinal cord. There are potential impacts on neurological functions, including sensory and autonomic functions. The Primary observed in males with MS is erectile dysfunction (ED), which substantially impacts the quality of life. There is increasing literature on electromagnetic fields' biological and clinical effects, particularly on ED.

Papers

Loading reviews and guidelines…

History

    1. Started

      Feb 2023

    2. Main results due

      Dec 2023

    3. Finished

      Mar 2024

    Assembled by software from public sources.